• DDM for Integrin Cryo-EM: Preserve the Ensemble

  2026-08-24

  Discover how n-Dodecyl-β-D-maltoside (DDM) can be used as a state-preservation variable in full-length membrane receptor workflows. This article translates recent αvβ3 cryo-EM findings into practical decisions for solubilization, purification, folding, and conformational assays.

• LmPLK1 Links Gut Renewal and Molting in Locusts

  2026-08-24

  This study characterizes Polo-like kinase 1 in Locusta migratoria and shows that LmPLK1 connects cell-cycle regulation with midgut maintenance, cuticle formation, hormone signaling, and insecticide susceptibility. RNA interference and 20-hydroxyecdysone rescue experiments identify LmPLK1 as a mechanistically informative and potentially useful target for locust management.

• Deferiprone for Reliable Cell Assays

  2026-08-23

  Learn how Deferiprone (SKU B1723) can be applied to cell viability, proliferation, cytotoxicity, and iron-stress experiments. This scenario-based guide covers ferric-ion chelation, aqueous formulation, dose and time optimization, data interpretation, and practical supplier selection.

• Dimethyloxalylglycine (DMOG) Workflow Guide

  2026-08-22

  Dimethyloxalylglycine (DMOG) provides a practical way to induce hypoxia-inducible factor stabilization through competitive inhibition of PHD enzymes, supporting controlled studies of oxygen sensing, hypoxia signaling, and inflammation. It is intended for laboratory and preclinical research only, not for diagnostic, therapeutic, or medical use, and experimental responses must be validated in the selected model.

• Mitochondrial Permeability Transition Pore Assay Kit

  2026-08-22

  Turn mitochondrial pore opening into a measurable green-fluorescence readout for compound screening, cell death mechanism research, and patient-derived cell studies. This workflow combines Calcein AM quenching with orthogonal measurements to distinguish permeability transition from nonspecific cell loss.

• TH287 MTH1 Inhibitor: Reliable Cell Assays

  2026-08-21

  Learn how TH287 MTH1 inhibitor, SKU B5849, can support reproducible viability, apoptosis, and radiosensitization experiments. This scenario-based guide connects formulation details with published evidence on oxidized nucleotide stress, DNA damage, and treatment timing.

• 10 mM dNTP mixture for PCR and DNA synthesis

  2026-08-20

  Build more consistent PCR, qPCR, sequencing, and DNA synthesis workflows with an equimolar nucleotide source designed for controlled DNA polymerization. This guide also shows how standardized DNA preparation can support, but should not be confused with, lipid nanoparticle trafficking studies.

• Tc3-Induced Pyroptosis in Hepatic Carcinoma

  2026-08-20

  A 2025 Theranostics study identified the indole analogue Tc3 as a gasdermin E-mediated pyroptosis inducer that suppresses hepatic carcinoma growth. The work also provides preclinical evidence that Tc3 can improve cisplatin activity and cooperate with anti-PD-1 treatment, while highlighting GSDME expression and tumor immune activation as important response factors.

• Triacetin in Ocular and Metabolic Research

  2026-08-19

  Triacetin, also called glyceryl triacetate, is more than an inert formulation aid: it can influence cellular, metabolic, and assay outcomes. This evidence-focused guide explains how ocular nanoemulsion research can improve Triacetin controls, interpretation, and translational decision-making.

• Annexin V-APC/7-AAD Apoptosis Kit: Assay Logic

  2026-08-19

  The Annexin V-APC/7-AAD Apoptosis Kit converts phosphatidylserine exposure and membrane integrity into an interpretable cell-death map. This guide connects assay design, flow-cytometry controls, and the PSA-CD56/Siglec-7 findings in clear cell renal cell carcinoma.

• MK-571: Decoding Macrophage Protection Assays

  2026-08-18

  MK-571 (L-660,711) is more than a leukotriene receptor antagonist: it is a powerful probe for separating cysLT1 signaling from ABCC1/MRP1-mediated drug transport. This article explains how recent macrophage findings should reshape assay design, controls, and interpretation.

• Brinzolamide Nanoemulsions: Ocular Safety and Permeation

  2026-08-18

  The reference study developed and screened brinzolamide-loaded nanoemulsions using complementary corneal permeation, retinal-cell viability, HET-CAM, and BCOP assays. Its main contribution was to connect improved ex vivo delivery with preliminary ocular safety, identifying formulation candidates that outperformed a marketed suspension without overstating their clinical readiness.

• GW 4869: Exosome Workflows in Lupus Nephritis

  2026-08-17

  GW 4869 hydrochloride hydrate enables a practical donor–recipient strategy for testing whether extracellular vesicle release contributes to glomerular endothelial injury. This guide combines neutral sphingomyelinase inhibition with cargo validation, normalization, and toxicity controls so reduced signaling is not mistaken for nonspecific cell damage.

• Pexidartinib (PLX3397) and CSF1R Translation

  2026-08-17

  Pexidartinib (PLX3397) offers a mechanistically focused way to interrogate CSF1R biology, macrophage behavior, and tumor–immune interactions. This thought-leadership article connects its use in cancer research with neuroimmune findings on microglial activation, while emphasizing experimental controls, translational boundaries, and opportunities beyond conventional product-page descriptions.

• Beyond Monocultures: Crizotinib in Tumor Assembloids

  2026-08-16

  Patient-derived gastric cancer assembloids expose how stromal context reshapes drug response. This article examines how Crizotinib hydrochloride can serve as a mechanistic probe for ALK, c-Met, and ROS1 signaling in translational cancer research.

7937 records 1/530 page Next 12345 下5页 Last page